Insights & Publications
WINDOME BANKING PARTNERS closes landmark stock for stock merger in the High-Tech Energy Based Devices segment in the US
May 2026WINDOME BANKING PARTNERS is pleased to announce that is has exclusively advised the BellaMia and DOMINION Aesthetics Technologies Group in the preparation, structuring, evaluation and execution of the strategic merger and integration of BellaMia into DOMINION Aesthetic Technologies, creating a broader and more scalable platform, with the capacity to offer a one-stop-shop of advanced medical aesthetic technologies for facial skin resurfacing and body reshaping and resculpting.
BellaMia Technoliges Inc / EON smarter body contouring
May 2026WINDOME BANKING PARTNERS acted as Exclusive Financial Advisors.
The SPFPL as a tool of sovereignty for the practitioner
May 2026Jean-Yves Coste, Chairman of WINDOME BANKING PARTNERS, warmly thanks Alexis JAVOURAY, President and Founder of Blue Filler, for this exchange on a key subject: the SPFPL as a tool of sovereignty for the practitioner.
The 3 KPIs to monitor to manage your business
April 2026Jean‑Yves Coste, President of WINDOME BANKING PARTNERS, and I would like to warmly thank Mr. Alexis Javouray.
Interview with Mr Jean-Yves COSTE at AMWC Monaco 2026
April 2026It was a great pleasure for WINDOME BANKING PARTNERS Management Team to be sharing my thoughts on the Sustainability of Sovereignty of medical aesthetics practices in the current fast changing and challenging technological, industrial and regulatory environments.
Participation at AMWC Monaco – March 28th, 2026
March 2026WINDOME BANKING PARTNERS is honoured to be represented thanks to the invitation of Mr. Jean-Yves Coste to speak at AMWC Monaco 2026, a landmark global meeting shaping the future of aesthetic and regenerative medicine.
We are honored to announce the appointment of Professor Albert-Claude Benhamou to the Scientific Board of Windome Banking Partners.
February 2026We are delighted to welcome Professor Albert-Claude Benhamou, University Professor and Hospital Practitioner, a renowned surgeon and leading opinion leader in the healthcare sector, who joins our Scientific Board to support our ambitions at the intersection of healthcare, technology, and finance.
WINDOME BANKING PARTNERS Announces the Appointment of Sébastien Truong
January 2026WINDOME BANKING PARTNERS announces the appointment of Sébastien Truong, effective January 5, 2026, as Chairman (Chief Executive Officer) of the “WINDOME REAL ESTATE” Business Unit.
The Crowley Center for Regenerative Biotherapeutics and SESDERMA S.L. have entered into a global, exclusive, and renewable 10-year Strategic Alliance
January 2026The Crowley Center for Regenerative Biotherapeutics and SESDERMA S.L. have entered into a global, exclusive, and renewable 10-year Strategic Alliance aimed at advancing regenerative medicine, longevity, and anti-aging therapies.
Crowley Center for Regenerative Biotherapeutics / Sesderma
January 2026Exclusive, renewable 10-year global strategic alliance Focused on co-development of regenerative products, including nano-liposomal encapsulated umbilical cord MSC-derived exosomes, co-formulation with Sesderma’s proprietary natural dermocosmetic actives, technology cross-licensing, and contract manufacturing.
Announcement regarding the conclusion of Mr. Florian PUCHLY’s position as General Manager
December 2025Evolution of Governance at WINDOME BANKING PARTNERS
Conference Adopt AI – Paris November 25-26
November 2025Last week’s ADOPT AI Conference at the Grand Palais proved a particularly exhilarating experience for me as I had the honour to showcase the spectacular advancements of MaisonEpigenetic…